Sino Biopharmaceutical (OTCMKTS:SBMFF) Shares Gap Down - Time to Sell?

Key Points

• Sino Biopharmaceutical's stock price gapped down from $1.24 to $1.15, with a trading volume of only 200 shares.
• The company has a 50-day moving average price of $0.95 and a 200-day moving average price of $0.67.
• Sino Biopharmaceutical operates in the pharmaceutical sector in China, focusing on various medicine segments, including oncology and respiratory treatments.

Sino Biopharmaceutical (OTCMKTS:SBMFF - Get Free Report)'s stock price gapped down before the market opened on Monday . The stock had previously closed at $1.24, but opened at $1.15. Sino Biopharmaceutical shares last traded at $1.15, with a volume of 200 shares traded.

Sino Biopharmaceutical Price Performance

The firm's 50 day simple moving average is $0.98 and its 200 day simple moving average is $0.68.

About Sino Biopharmaceutical

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, pomalidomide capsules under Anyue brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, and trastuzumab for injection under Saituo brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand and colistimethate sodium for injection under Tianyun brand.